Aspen Aerogels/$ASPN
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Aspen Aerogels
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology, supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Thermal Barrier segment and the United States market. Some of its products include Pyrogel XTE, Cryogel Z, Spaceloft Subsea, and others.
- Ticker
- $ASPN
- Sector
- Materials
- Primary listing
- NYSE
- Employees
- 854
- Headquarters
- Northborough, United States
- Website
- www.aerogel.com
Aspen Aerogels Metrics
BasicAdvanced
$400M
-
-$1.53
2.97
-
Price and volume
Market cap
$400M
Beta
2.97
52-week high
$8.24
52-week low
$2.30
Average daily volume
988K
Financial strength
Current ratio
2.519
Quick ratio
1.946
Long term debt to equity
0.478
Total debt to equity
0.65
Interest coverage (TTM)
-5.81%
Profitability
EBITDA (TTM)
-46.331
Gross margin (TTM)
13.61%
Net profit margin (TTM)
-62.45%
Operating margin (TTM)
-33.34%
Effective tax rate (TTM)
-0.69%
Revenue per employee (TTM)
$240,000
Management effectiveness
Return on assets (TTM)
-9.17%
Return on equity (TTM)
-50.36%
Valuation
Price to revenue (TTM)
1.972
Price to book
2.08
Price to tangible book (TTM)
2.08
Price to free cash flow (TTM)
11.591
Free cash flow yield (TTM)
8.63%
Free cash flow per share (TTM)
0.416
Growth
Revenue change (TTM)
-49.12%
Earnings per share change (TTM)
-60.57%
3-year revenue growth (CAGR)
2.07%
10-year revenue growth (CAGR)
4.55%
3-year earnings per share growth (CAGR)
6.54%
10-year earnings per share growth (CAGR)
23.82%
What the Analysts think about Aspen Aerogels
Analyst ratings (Buy, Hold, Sell) for Aspen Aerogels stock.
Analyst projections of the future price of Aspen Aerogels stock.
Bulls say / Bears say
Europe is becoming a meaningful second growth engine: Aspen raised its 2026 European thermal-barrier revenue outlook to $20–30 million and won a Jaguar Land Rover award covering two next-generation vehicle platforms. Management targets $40–60 million of European OEM revenue in 2027 as more programmes reach production. (Aspen Aerogels, SEC)
Energy Industrial offers growth beyond the EV cycle: management is targeting about 20% revenue growth in 2026, with LNG and subsea projects expected to lift second-half deliveries. It says LNG activity should more than double this year and sees a project pipeline extending into 2027 and beyond. (Investing.com)
The near-term outlook points to a sharp recovery in sales and a return to positive adjusted EBITDA: Aspen forecast Q3 revenue of $65–80 million and adjusted EBITDA of $7–15 million, against Q2 revenue of $49.8 million. It ended June with $153.4 million of cash, while 2026 capital spending excluding plant-restoration costs is expected below $10 million. (Aspen Aerogels)
Thermal Barrier sales remain exposed to a weak and unpredictable EV market: Q2 segment revenue fell to $29.5 million from $55.2 million a year earlier, and Aspen attributed the decline to lower North American EV production and changing incentives. Total first-half revenue was down 44% year on year. (SEC)
The East Providence explosion creates a serious operational and safety overhang. OSHA cited Aspen for willful safety violations after the incident, while the company says full plant capacity is not expected until the first half of 2027 and has flagged additional repair and disruption costs. (Providence Business First, SEC)
A key customer contract offers limited volume protection: GM has no minimum purchase requirement under its thermal-barrier agreements and can terminate them at any time. That leaves Aspen’s sales vulnerable to customer production changes even where a programme has been awarded. (SEC)
Data summarised monthly by Lightyear AI. Last updated on 30 Oct 2026.
Aspen Aerogels Financial Performance
Revenues and expenses
Aspen Aerogels Earnings Performance
Company profitability
Upcoming events
No upcoming events
Aspen Aerogels News
AllArticlesVideos
Funds containing Aspen Aerogels
Fund name | Fund size | $ASPN weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.01% |
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.